| Advanced Medical Dme Llc | |
| 3520 Lakin Ave, Ste 110, Great Bend, Kansas 67530 | |
| (620) 797-9242 |
| Name | Advanced Medical Dme Llc |
|---|---|
| Organization Name | Advanced Medical Dme Llc |
| Location | 3520 Lakin Ave, Ste 110, Great Bend, Kansas 67530 |
| Type | Supplier |
| Phone | (620) 797-9242 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Many low- and middle-income countries are neglecting overweight and obesity as major health threats, with policies in place to tackle undernutrition, but lack policies to halt the growing burden of diseases due to the rise of overweight, and obesity, according to new information released by WHO today.
Monash University researchers have discovered that the devastating bacterial superbug Clostridioides difficile hijacks the human wound healing system in order to cause serious and persistent disease, opening up the development of new therapies to treat the disease.
Bacteria provide a well-known playground for scientists and the evolution of these earliest life forms has shed important perspective on potential therapies for some of the most common, deadly diseases. Researchers at Case Western Reserve University School of Medicine have now discovered that, the gas nitric oxide (NO), produced in all cells of the human body for natural purposes, plays a fundamental regulatory role in controlling bacterial function, via a signaling mechanism called S-nitrosylation (SNO), which binds NO to protein molecules.
People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.
› Verified 1 days ago
News Archive
Many low- and middle-income countries are neglecting overweight and obesity as major health threats, with policies in place to tackle undernutrition, but lack policies to halt the growing burden of diseases due to the rise of overweight, and obesity, according to new information released by WHO today.
Monash University researchers have discovered that the devastating bacterial superbug Clostridioides difficile hijacks the human wound healing system in order to cause serious and persistent disease, opening up the development of new therapies to treat the disease.
Bacteria provide a well-known playground for scientists and the evolution of these earliest life forms has shed important perspective on potential therapies for some of the most common, deadly diseases. Researchers at Case Western Reserve University School of Medicine have now discovered that, the gas nitric oxide (NO), produced in all cells of the human body for natural purposes, plays a fundamental regulatory role in controlling bacterial function, via a signaling mechanism called S-nitrosylation (SNO), which binds NO to protein molecules.
People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.
› Verified 1 days ago
Advanced Medical Dme Llc Type: Medicare Supplier Location: 3520 Lakin Ave, Great Bend, Kansas 67530 Phone: (620) 797-9242 | |
Alternacare Home Health Services In Type: DME Supplier - Oxygen Equipment & Supplies Location: 2708 10th St, Great Bend, Kansas 67530 Phone: (620) 793-3700 | |
Dillon Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4107 10th St, Great Bend, Kansas 67530 Phone: (620) 795-2944 | |
The 10th Street Eyecare Center Type: Medicare Supplier Location: 2601 10th St, Great Bend, Kansas 67530 Phone: (620) 792-2020 | |
Medical Park Pharmacy Of Great Bend Type: Community/Retail Pharmacy Location: 1309 Polk St, Great Bend, Kansas 67530 Phone: (620) 792-1221 |